In the pipeline
Number of drugs in development by New York companies
Employment
Number of biotechnology employees in New York†
†Includes only those companies still in existence or operating in the state in 2002
Facts and figures
• New York is home to 101 biotechnology companies, more than half of which focus on the development of new therapeutic products and related drug-delivery technologies
• For every public biotech company in New York state, there are about three private ones
• The public companies within this group have a combined market capitalization of approximately $8.6 billion
Source: New York Biotechnology Assoc., "2004 State of the Industry Report"
- Francesco Fiondella
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
